Publications by authors named "Baixue Yu"

Claim this Profile
M
MicroRNA-26b-/- augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis.
Linsey J F Peters, Kiril Bidzhekov, Andrea Bonnin-Marquez, Sai Sahana Sundararaman, Rosanna Huchzermeier, Baixue Yu

Cardiovasc Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation.
Yi Cen, Xin-Xuan Li, Ying Chen, Xiao-Cheng Ou, Bai-Xue Yu, Xia-Yun Chen

ACS Appl Mater Interfaces· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation.
Han Jin, Sanne L Maas, Yuchi Zou, Chang Lu, Baixue Yu

Genome Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Promoting Targeted Delivery of Epigenetic Immunostimulants to Activate Breast Cancer Immunity via HDACs Downregulation and PD-L1 Upregulation.
Xiayun Chen, Lichong Lu, Ziqi Liang, Baixue Yu, Zhouchuan Shao, Xiaoyuan Chen

Angew Chem Int Ed Engl· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-promoted tumor-targeting nanomedicine activates STING-driven antitumor immunity photodynamic DNA damage and PARP inhibition.
Baixue Yu, Wei Zhang, Zhouchuan Shao, Xiayun Chen, Yi Cen, Xiaoyuan Chen

Chem Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosis.
Baixue Yu, Miron Sopic, Judith C Sluimer

Vascul Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CXCR4-targeted immunomodulatory nanomedicine for photodynamic amplified immune checkpoint blockade therapy against breast cancer.
Yibin Liu, Xiayun Chen, Wei Zhang, Baixue Yu, Yi Cen

Acta Biomater· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Peptide Functionalized Immunostimulant to Orchestrate Photodynamic Immunotherapeutic Effect by PD-L1 Deglycosylation and CD47 Inhibition.
Yi Cen, Xin-Xuan Li, Min Wang, Ying Chen, Xiao-Cheng Ou, Bai-Xue Yu, Xia-Yun Chen, Yu-Qing Wang

ACS Appl Mater Interfaces· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Peptide-Engineered Polyprodrug Enhances Cytotoxic T Cell Response by Inducing Immunogenic Cell Death and Upregulating Major Histocompatibility Complex Class I.
Ying Chen, Yi Cen, Xin-Xuan Li, Xiao-Cheng Ou, Xia-Yun Chen, Bai-Xue Yu, Rui Yu

ACS Nano· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through -catenin/CREB interruption.
Mengyi Yan, Xiayun Chen, Xiaotong Li, Qianqian Liu, Baixue Yu

Acta Pharm Sin B· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Assembled PD-L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition.
Bai-Xue Yu, Yi-Bin Liu, Xia-Yun Chen, Wei Zhang, Yi Cen

Small· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Homing Chimeric Peptide Rhomboids to Improve Photodynamic Performance by Inhibiting Therapy-Upregulated Cyclooxygenase-2.
Wei Zhang, Bai-Xue Yu, Xia-Yun Chen, Meng-Yi Yan, Qian-Qian Liu

Small· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy.
Yi Cen, Ying Chen, Xinxuan Li, Xiayun Chen, Baixue Yu

Biomaterials· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Peptide-Engineered Self-Delivery Nanomedicine for Photodynamic-Triggered Breast Cancer Immunotherapy by Macrophage Polarization.
Yi-Bin Liu, Xia-Yun Chen, Bai-Xue Yu, Yi Cen, Chu-Yu Huang

Small· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycolytic enzyme PFKFB3 regulates sphingosine 1-phosphate receptor 1 in proangiogenic glomerular endothelial cells under diabetic condition.
Baixue Yu, Kaiyuan Shen, Tingting Li, Jiawei Li, Mei Meng, Tongyu Zhu

Am J Physiol Cell Physiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of PHACTR4 as A New Biomarker for Diabetic Nephropathy and Its Correlation with Glomerular Endothelial Dysfunction and Immune Infiltration.
Baixue Yu, Mei Meng, Tingting Li, Yi Shi

Iran J Kidney Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Peptide Engineered Bioregulator for Metastatic Tumor Immunotherapy through Macrophage Polarization and Phagocytosis Restoration.
Xia-Yun Chen, Meng-Yi Yan, Qianqian Liu, Bai-Xue Yu, Yi Cen

ACS Nano· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug induced mitochondria dysfunction to enhance photodynamic therapy of hypoxic tumors.
Yi Cen, Xiayun Chen, Yibin Liu, Baixue Yu, Mengyi Yan

J Control Release· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carrier free nanomedicine for synergistic cancer therapy by initiating apoptosis and paraptosis.
Rongrong Zheng, Yibin Liu, Baixue Yu, Linping Zhao, Ni Yang

J Colloid Interface Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Membrane-Targeted Photooxidant for Chemotherapy-Enhanced Lipid Peroxidation.
Fu-An Deng, Meng-Yi Yan, Yi-Bin Liu, Bai-Xue Yu, Jia-Qi Huang

ACS Appl Bio Mater· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy.
Yibin Liu, Fuan Deng, Rongrong Zheng, Xiayun Chen, Linping Zhao, Baixue Yu

J Colloid Interface Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian misalignment promotes vascular smooth muscle cell apoptosis via defective autophagy.
Zhenyu Guo, Baixue Yu, Xu Li, Xiaohu Yang, Chen Wang

J Mol Histol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major histocompatibility complexes are up-regulated in glomerular endothelial cells via activation of c-Jun N-terminal kinase in 5/6 nephrectomy mice.
Dong Zhu, Qunye Tang, Baixue Yu, Mei Meng, Wenjie Liu, Tongyu Zhu

Br J Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation.
Mei Meng, Weitao Zhang, Qunye Tang, Baixue Yu, Tingting Li, Tongyu Zhu

BMC Med Genomics· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis